DISEASE ACTIVITY, STERIOD-FREE REMISSION, AND CLINICAL OUTCOME ASSESSMENTS OF PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY

To assess disease activity, steroid-free remission, and clinical outcome assessments among pediatric UC and CD patients who initiated a biologic after being enrolled in the ICN registry.

This entry was posted in News. Bookmark the permalink.